887 related articles for article (PubMed ID: 2420891)
1. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
2. High cytotoxic activity against herpes simplex virus type 1 infected targets found in murine peritoneum.
Brownridge E; Lopez C
Nat Immun Cell Growth Regul; 1986; 5(6):294-304. PubMed ID: 2432414
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
Tamesis RR; Foster CS
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
[TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
5. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
Muñoz A; Carrasco L; Fresno M
J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
[TBL] [Abstract][Full Text] [Related]
7. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
Bukowski JF; Welsh RM
J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
[TBL] [Abstract][Full Text] [Related]
8. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
9. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
10. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
11. Role of interferon in natural kill of HSV-1-infected fibroblasts.
Fitzgerald PA; von Wussow P; Lopez C
J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
[TBL] [Abstract][Full Text] [Related]
12. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
Bukowski JF; Welsh RM
J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
Stein-Streilein J; Bennett M; Mann D; Kumar V
J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
[TBL] [Abstract][Full Text] [Related]
14. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.
Brutkiewicz RR; Klaus SJ; Welsh RM
Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
16. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
Fitzgerald PA; Mendelsohn M; Lopez C
J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
[TBL] [Abstract][Full Text] [Related]
17. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
[TBL] [Abstract][Full Text] [Related]
18. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
Hendricks RL; Sugar J
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):201-7. PubMed ID: 2579040
[TBL] [Abstract][Full Text] [Related]
19. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
Paya CV; Schoon RA; Leibson PJ
J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
[TBL] [Abstract][Full Text] [Related]
20. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1.
Brandt CR; Salkowski CA
Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):113-20. PubMed ID: 1370438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]